Detailed pricing plans are not available yet for this tool.
Skip to content A history of shaping guidelines The future of transformative care See how we enhance clinical decision-making Clinical Solutions Deep Clinical AI Enterprise Platform AI Programs Impact Mobile App Quick Links Clinical Solutions Deep Clinical AI Enterprise Platform AI Programs Impact Mobile App Cutting-edge solutions Neurovascular Enhance stroke, trauma, and aneurysm care Cardiac & Vascular Modernize how you manage pulmonary embolism care Radiology Boost diagnostic confidence and streamline workflows Life Sciences Drive clinical trials with quality patient enrollment Our impact, quantified 2,500+ hospitals 100+ countries 14 FDA cleared modules 17.5 impact factor 20k+ daily scans 11 NEJM publications 700+ publications 25+ trials Premier platform, meaningful performance The Rapid Enterprise™ Platform enables the cross-disciplinary deployment of deep clinical AI, bringing the value of clinically backed decision support to various healthcare professionals. Clinical solutions Deep clinical decision-making support for various disease states Rapid mobile app Real-time collaboration and alerts for urgent cases Navigator Pro Imaging prioritization and AI decision support for Radiology Rapid Insights Custom performance analytics platform Third-party integration Interoperability framework connecting the healthcare ecosystem Optimized service lines Power your service lines with AI-driven precision—boost revenue, attract top talent, and enhance patient care. Enhance patient outcomes Enhance patient outcomes Advanced clinical AI delivers real-time insights for faster, more confident decision-making at scale. Drive operational efficiency Drive operational efficiency Streamline workflows with smarter resource allocation and seamless cross-network coordination. Strengthen financial viability Strengthen financial viability High-performing service lines enhance reputation, drive referrals, and maximize revenue—starting with smarter transfer and treatment decisions. Deep clinical AI Our platform delivers more than anomaly detection—it gives doctors the ability to see and do more with ease. Clinical validation Actionable insights Disease state expertise Backed by the industry's most extensive clinical rigor 700+ publications 25+ clinical trials 11 NEJM publications 17.5 impact factor Triage Triage Rapidly identify suspected anomalies Localization Localization View regions of concern Quantification Quantification Automate key metrics like blood flow + anomaly growth Characterization Characterization Assess anomaly severity + morphology Visualization Visualization View automated 3D renderings + AI outputs Longitudinal tracking Longitudinal tracking Monitor changes over time Where others start broad, we start deep. With deep expertise in critical disease states, we provide solutions that equip clinicians with the insights needed to drive meaningful impact. NEUROVASCULAR CARDIAC & VASCULAR RADIOLOGY Power in your palm Stay connected to critical cases, from the ER to the OR and everywhere in between. Get notified of suspected cases in real time Review AI outputs and source imaging in the DICOM viewer Coordinate across teams and sites with in-app messaging Consult with colleagues across the system Customize notifications based on clinical thresholds Initiate procedural workflows with a single touch Review patient case summaries with EMR integration Get notified of suspected cases in real time Review AI outputs and source imaging in the DICOM viewer Coordinate across teams and sites with in-app messaging Consult with colleagues across the system Customize notifications based on clinical thresholds Initiate procedural workflows with a single touch Review patient case summaries with EMR integration Get to know Rapid in the real world View All Resources Press release RapidAI Highlights Research Depth and Industry Leadership at ISC 2026 With 28 Clinical Abstracts New clinical data show AI-driven gains in aneurysm growth detection, stroke interpretation accuracy, and radiology workflow efficiency across enterprise imaging environments Press release Lumina 3D by RapidAI Named to TIME’s List of the Best Inventions of 2025 This recognition highlights our commitment to advancing deep clinical AI that enhances physician performance and operational efficiency Article Using AI to improve stroke outcomes in rural Missouri: “We can save your life." This story highlights how rural hospitals like TCMH in Missouri are using its AI-powered stroke software to improve local stroke outcomes Ready to see the difference for yourself? REQUEST A DEMO 094-MKT-Web-1224 --- Skip to content Meet Rapid We do AI differently Rooted in clinical validation and fueled by curiosity, we innovate with purpose—delivering AI-powered medical imaging and care coordination solutions that transform decision-making and improve patient outcomes. Where depth meets breadth Our platform drives one clear path to enhanced care, no matter where a patient seeks treatment. We do AI better because we go beyond the algorithm. Instill confidence Instill confidence Through AI-driven imaging insights backed by copious amounts of clinical validation. Drive efficiencies Drive efficiencies In care team collaboration to mitigate workflow friction and wasted time. Expand access Expand access To specialists, even if they’re miles away, for more equitable care. Our history Changing minds and guidelines We never bought into the decades-long concept that stroke treatment had to be limited to a few short hours after the last-known well. We theorized that stroke damage was highly variable, contrary to accepted beliefs, and that far more people could be saved with the right technology. We developed Rapid to be the engine of transformation in stroke treatment. And it did exactly what we thought it could. After years of landmark clinical trials validating Rapid, worldwide stroke guidelines expanded the treatment window from 6 to 24 hours. The Rapid [R]evolution. 2008 2018 2021 2022 2023 2024 2025 2008 2018 2021 2022 2023 2024 2025 2008 2008 The first fully automated image processing platform for Neurology at Stanford University 2018 2018 Based on the DAWN and DEFUSE 3 clinical trials that used Rapid imaging to select stroke patients for late-window treatment, the American Heart and American Stroke associations revise guidelines, extending the treatment window for acute stroke patients from 6 to 24 hours 2021 2021 Becomes the leading global AI provider in 60+ countries and 2000+ sites 2022 2022 Expands scope from stroke to Cardiovascular, Endovascular, Aneurysm & Trauma 2023 2023 Launches first in-class Edge Cloud platform, non-contrast CT Imaging for ischemic stroke 2024 2024 The Rapid Enterprise™ Platform and Navigator Pro™ are launched, expanding key solutions to radiology 2025 2025 Lumina 3D™ by RapidAI is launched 2025 Rapid LVO demonstrates superiority over Viz LVO View full-timeline × Ready to experience Rapid? Book a demo 184-MKT-web-0325 --- This site uses cookies to deliver superior functionality and enhance your experience. By continuing to use this site, you consent to the use of cookies. For more information, view our Privacy Policy Accept Decline Skip to content Customer Support We’re here to help Contact our dedicated customer support team 24/7 via email at support@rapidai.com. You can also speak with one of our experienced technical services experts by phone at the numbers listed below. United States 1-833-RAPIDAI (833 727 4324) Australia +61 2 8074 3445 Belgium +32 800 12 783 Brazil +55 13 4040 4298 Canada 1 647 360 0966 France +33 8 00 90 87 58 Germany +49 800 1818296 India 00 80005 03724 Italy +39 800 985 625 Japan +81 3 5937 6061 Netherlands +31 800 0232995 United Kingdom +44 330 094 5547 The RapidAI services team is fluent in the following languages Arabic Czech English French German Mandarin Polish Portuguese Romanian Serbian Slovak Spanish Urdu/Hindi Thank you for choosing RapidAI RapidAI is here to empower users to make faster decisions for better patient outcomes. We provide end-to-end support to help healthcare professionals use our platform with confidence and ease. Reach out to us if you need assistance. CONTACT US 255-MKT-Web-0425 × We Value Your PrivacySettingsNextRoll, Inc. ("NextRoll") and our 20 advertising partners use cookies and similar technologies on this site and use personal data (e.g., your IP address). If you consent, the cookies, device identifiers, or other information can be stored or accessed on your device for the purposes described below. You can click "Allow All" or "Decline All" or click Settings above to customise your consent regarding the purposes and features for which your personal data will be processed and/or the partners with whom you will share personal data.NextRoll and our advertising partners process personal data to: ● Store and/or access information on a device; ● Create a personalised content profile; ● Select personalised content; ● Personalised advertising, advertising measurement, audience research and services development; ● Services development. For some of the purposes above, our advertising partners: ● Use precise geolocation data. Some of our partners rely on their legitimate business interests to process personal data. View our advertising partners if you wish to provide or deny consent for specific partners, review the purposes each partner believes they have a legitimate interest for, and object to such processing.If you select Decline All, you will still be able to view content on this site and you will still receive advertising, but the advertising will not be tailored for you. You may change your setting whenever you see the on this site.Decline AllAllow All --- Skip to content Contact us Let’s connect If you’re interested in partnerships, press inquiries, careers, or have a general question, fill out the form and we’ll get back to you as soon as possible. For sales or demo requests, click here. If you’re a current customer looking for support, call 1-833-RAPIDAI or send us an email at support@rapidai.com The decision we ultimately made was based largely on data from the RapidAI perfusion imaging. To have perfusion data say that this patient has a 200CC area of potential at risk, it helps give you that confidence that it's important to intervene. David Fiorella, MD Director, Stony Brook Cerebrovascular Center,Co-Director, Stony Brook Cerebrovascular and Comprehensive Stroke Center Connect with our team
